TMCnet News

Research and Markets: Dermatitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014-2015
[January 16, 2015]

Research and Markets: Dermatitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014-2015


Research and Markets (http://www.researchandmarkets.com/research/dtkjkf/dermatitis_market) has announced the addition of the "Dermatitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014" report to their offering.

Dermatitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication.

A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India.

The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Key Topics Covered:

  1. Indication Overview
  2. Marketed Drugs Assessment
  3. Marketed Details of Drugs by Application Type
  4. Marketed Details f Drugs (NDA) by Marketing Status
  5. Marketed Details of Drugs by Patent Expiration Timeline (News - Alert)
  6. The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
  7. The API Manufacturers by the United States Drug Master File (US DMF) Status
  8. The API Manufacturers by the US DMF Status (Drug Specific)
  9. The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
  10. The API Manufacturers by the US DMF Status (Drug Specific)
  11. Drugs Market Data and Forecasted Sales Figures (2011-2015)
  12. Marketed Drugs Information
  13. Drugs Description
  14. Route of Synthesis
  15. Global Active Pharmaceutical Manufacturers
  16. Approval Status
  17. Patent and Exclusivity Details
  18. Company Overview
  19. Phase III Drugs Information
  20. Phase III Drugs Description
  21. The United States Drug Master Filings (US DMF)
  22. Discontinued Drugs Information



Companies Mentioned

  • Allergan, Inc.
  • Astellas Pharma US, Inc.
  • Horizon Pharma, Inc.
  • Quinnova Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Bayer HealthCare Pharmaceuticals Inc.
  • Stiefel Laboratories, Inc.
  • AbbVie Inc.
  • Pfizer Inc.
  • Pharmacia & Upjohn, Inc.
  • Roxane Laboratories, Inc.
  • PharmaDerm
  • Prestium Pharma, Inc.
  • Aqua Pharmaceuticals, LLC
  • Lilly USA, LLC
  • Novartis Pharmaceuticals Corporation
  • Astellas Pharma Inc.
  • Organon USA Inc.
  • Apothecon Inc
  • Schering-Plough HealthCare Products, Inc
  • Schering-Plough Corporation (Inactive)
  • Taro Pharmaceutical Industries Ltd.
  • Merck Sharp (News - Alert) & Dohme Corp.
  • Onset Dermatologics
  • Standard Homeopathic Company
  • Sandoz Inc.
  • Panray Corporation
  • UCB, Inc.
  • Concordia Pharmaceuticals Inc.
  • Medimetriks Pharmaceuticals, Inc.

For more information visit http://www.researchandmarkets.com/research/dtkjkf/dermatitis_market


About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To TMCnet.com's Homepage ]